Prenetics Group (PRE) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Prenetics Global Limited reported a remarkable 59.4% revenue growth in the third quarter of 2024, reaching $7.8 million, fueled by the successful launch of its new premium supplements brand, IM8Health.com, and strategic expansion in the U.S. market. Additionally, Tencent’s $30 million investment in Prenetics’ early cancer detection venture, Insighta, underscores investor confidence in the company’s innovative health solutions. With a strengthened financial position and ambitious revenue targets, Prenetics is poised for continued growth in the health sciences sector.
For further insights into PRE stock, check out TipRanks’ Stock Analysis page.
